Continuation or Discontinuation of Statin Therapy Did Not Influence Patient Outcomes after the Development of Acute Respiratory Distress Syndrome
Table 2
Outcome results.
Characteristic
Statin before and after ARDS ()
Statin before but not after ARDS ()
Statin never ()
value
VFDs through day 28
0 (0–19)
4.5 (0–16.0)
13.5 (0–20.0)
0.21
ICU mortality
9 (52.9)
7 (35.0)
37 (24.7)
0.04
Hospital mortality
12 (70.6)
7 (35.0)
49 (32.7)
0.009
28-day mortality
9 (52.9)
6 (30.0)
39 (26.0)
0.067
ICU LOS
14.0 (5.5–23.5)
12.0 (7.0–23.8)
11.0 (7.0–20.0)
0.83
Hospital LOS
21 (15.5–33.0)
28.0 (15.5–40.5)
23.0 (15.0–35.3)
0.79
Data presented (%) or as median (IQR). ARDS: acute respiratory distress syndrome; VFDs: ventilator-free days; ICU: intensive care unit; LOS: length of stay.
